5-HT3 receptor antagonist, Antiemetic, Cisplatin, Dolasetron, Metoclopramide
dx.doi.org/10.1007/s005200050036, hdl.handle.net/1765/61692
Supportive Care in Cancer
Department of Medical Oncology

Chevallier, P, Cappelaere, P, Splinter, T.A.W, Fabbro, M, Wendling, J.L, Cals, L, … Claverie, N. (1997). A double-blind, multicentre comparison of intravenous dolasetron mesilate and metoclopramide in the prevention of nausea and vomiting in cancer patients receiving high-dose cisplatin chemotherapy. Supportive Care in Cancer, 5(1), 22–30. doi:10.1007/s005200050036